spot_img
8.7 C
London
HomeInvestors HealthEagle Pharmaceuticals receives delisting notification from Nasdaq

Eagle Pharmaceuticals receives delisting notification from Nasdaq


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here